NLK upregulation leads directly to cytoplasmic accumulation of TDP43 and other RNA-binding proteins associated with ALS, and reduction in NLK promotes the survival of iPSC-derived neurons carrying ALS-associated mutations. The gene discussed is SRRM2; the disease is amyotrophic lateral sclerosis.